The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Neglected Tropical Diseases Diagnosis-Global Market Insights and Sales Trends 2025
Synopsis
Neglected Tropical Diseases Diagnosis is the procedure to test if the patient have the Neglected Tropical.
The global Neglected Tropical Diseases Diagnosis market size is expected to reach US$ 8008.3 million by 2029, growing at a CAGR of 3.5% from 2023 to 2029. The market is mainly driven by the significant applications of Neglected Tropical Diseases Diagnosis in various end use industries. The expanding demands from the Clinical Labs, Hospitals /Clinics and Home Healthcare,, are propelling Neglected Tropical Diseases Diagnosis market. Conventional Method, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Molecular/Modern Method segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Neglected Tropical Diseases Diagnosis, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Neglected Tropical Diseases Diagnosis market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Neglected Tropical Diseases Diagnosis market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Neglected Tropical Diseases Diagnosis sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Neglected Tropical Diseases Diagnosis covered in this report include Abbott Laboratories, Beckman Coulter/Danaher, Bio-Rad Laboratories, Inc., Life Technology, Novartis Diagnostics., Ltd., Ortho-Clinical Diagnostics, Premier Medical Corporation Ltd., Siemens Healthcare and Wako Chemicals, Inc., etc.
The global Neglected Tropical Diseases Diagnosis market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Abbott Laboratories
Beckman Coulter/Danaher
Bio-Rad Laboratories, Inc.
Life Technology
Novartis Diagnostics., Ltd.
Ortho-Clinical Diagnostics
Premier Medical Corporation Ltd.
Siemens Healthcare
Wako Chemicals, Inc.
Global Neglected Tropical Diseases Diagnosis market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Neglected Tropical Diseases Diagnosis market, Segment by Type:
Conventional Method
Molecular/Modern Method
Global Neglected Tropical Diseases Diagnosis market, by Application
Clinical Labs
Hospitals /Clinics
Home Healthcare
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Neglected Tropical Diseases Diagnosis companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Neglected Tropical Diseases Diagnosis is the procedure to test if the patient have the Neglected Tropical.
The global Neglected Tropical Diseases Diagnosis market size is expected to reach US$ 8008.3 million by 2029, growing at a CAGR of 3.5% from 2023 to 2029. The market is mainly driven by the significant applications of Neglected Tropical Diseases Diagnosis in various end use industries. The expanding demands from the Clinical Labs, Hospitals /Clinics and Home Healthcare,, are propelling Neglected Tropical Diseases Diagnosis market. Conventional Method, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Molecular/Modern Method segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Neglected Tropical Diseases Diagnosis, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Neglected Tropical Diseases Diagnosis market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Neglected Tropical Diseases Diagnosis market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Neglected Tropical Diseases Diagnosis sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Neglected Tropical Diseases Diagnosis covered in this report include Abbott Laboratories, Beckman Coulter/Danaher, Bio-Rad Laboratories, Inc., Life Technology, Novartis Diagnostics., Ltd., Ortho-Clinical Diagnostics, Premier Medical Corporation Ltd., Siemens Healthcare and Wako Chemicals, Inc., etc.
The global Neglected Tropical Diseases Diagnosis market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Abbott Laboratories
Beckman Coulter/Danaher
Bio-Rad Laboratories, Inc.
Life Technology
Novartis Diagnostics., Ltd.
Ortho-Clinical Diagnostics
Premier Medical Corporation Ltd.
Siemens Healthcare
Wako Chemicals, Inc.
Global Neglected Tropical Diseases Diagnosis market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Neglected Tropical Diseases Diagnosis market, Segment by Type:
Conventional Method
Molecular/Modern Method
Global Neglected Tropical Diseases Diagnosis market, by Application
Clinical Labs
Hospitals /Clinics
Home Healthcare
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Neglected Tropical Diseases Diagnosis companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Neglected Tropical Diseases Diagnosis
1.1 Neglected Tropical Diseases Diagnosis Market Overview
1.1.1 Neglected Tropical Diseases Diagnosis Product Scope
1.1.2 Neglected Tropical Diseases Diagnosis Market Status and Outlook
1.2 Global Neglected Tropical Diseases Diagnosis Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Neglected Tropical Diseases Diagnosis Market Size by Region (2018-2029)
1.4 Global Neglected Tropical Diseases Diagnosis Historic Market Size by Region (2018-2023)
1.5 Global Neglected Tropical Diseases Diagnosis Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Neglected Tropical Diseases Diagnosis Market Size (2018-2029)
1.6.1 North America Neglected Tropical Diseases Diagnosis Market Size (2018-2029)
1.6.2 Europe Neglected Tropical Diseases Diagnosis Market Size (2018-2029)
1.6.3 Asia-Pacific Neglected Tropical Diseases Diagnosis Market Size (2018-2029)
1.6.4 Latin America Neglected Tropical Diseases Diagnosis Market Size (2018-2029)
1.6.5 Middle East & Africa Neglected Tropical Diseases Diagnosis Market Size (2018-2029)
2 Neglected Tropical Diseases Diagnosis Market by Type
2.1 Introduction
2.1.1 Conventional Method
2.1.2 Molecular/Modern Method
2.2 Global Neglected Tropical Diseases Diagnosis Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Neglected Tropical Diseases Diagnosis Historic Market Size by Type (2018-2023)
2.2.2 Global Neglected Tropical Diseases Diagnosis Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Neglected Tropical Diseases Diagnosis Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Neglected Tropical Diseases Diagnosis Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Neglected Tropical Diseases Diagnosis Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Neglected Tropical Diseases Diagnosis Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Neglected Tropical Diseases Diagnosis Revenue Breakdown by Type (2018-2029)
3 Neglected Tropical Diseases Diagnosis Market Overview by Application
3.1 Introduction
3.1.1 Clinical Labs
3.1.2 Hospitals /Clinics
3.1.3 Home Healthcare
3.2 Global Neglected Tropical Diseases Diagnosis Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Neglected Tropical Diseases Diagnosis Historic Market Size by Application (2018-2023)
3.2.2 Global Neglected Tropical Diseases Diagnosis Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Neglected Tropical Diseases Diagnosis Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Neglected Tropical Diseases Diagnosis Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Neglected Tropical Diseases Diagnosis Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Neglected Tropical Diseases Diagnosis Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Neglected Tropical Diseases Diagnosis Revenue Breakdown by Application (2018-2029)
4 Neglected Tropical Diseases Diagnosis Competition Analysis by Players
4.1 Global Neglected Tropical Diseases Diagnosis Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Neglected Tropical Diseases Diagnosis as of 2022)
4.3 Date of Key Players Enter into Neglected Tropical Diseases Diagnosis Market
4.4 Global Top Players Neglected Tropical Diseases Diagnosis Headquarters and Area Served
4.5 Key Players Neglected Tropical Diseases Diagnosis Product Solution and Service
4.6 Competitive Status
4.6.1 Neglected Tropical Diseases Diagnosis Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Abbott Laboratories
5.1.1 Abbott Laboratories Profile
5.1.2 Abbott Laboratories Main Business
5.1.3 Abbott Laboratories Neglected Tropical Diseases Diagnosis Products, Services and Solutions
5.1.4 Abbott Laboratories Neglected Tropical Diseases Diagnosis Revenue (US$ Million) & (2018-2023)
5.1.5 Abbott Laboratories Recent Developments
5.2 Beckman Coulter/Danaher
5.2.1 Beckman Coulter/Danaher Profile
5.2.2 Beckman Coulter/Danaher Main Business
5.2.3 Beckman Coulter/Danaher Neglected Tropical Diseases Diagnosis Products, Services and Solutions
5.2.4 Beckman Coulter/Danaher Neglected Tropical Diseases Diagnosis Revenue (US$ Million) & (2018-2023)
5.2.5 Beckman Coulter/Danaher Recent Developments
5.3 Bio-Rad Laboratories, Inc.
5.3.1 Bio-Rad Laboratories, Inc. Profile
5.3.2 Bio-Rad Laboratories, Inc. Main Business
5.3.3 Bio-Rad Laboratories, Inc. Neglected Tropical Diseases Diagnosis Products, Services and Solutions
5.3.4 Bio-Rad Laboratories, Inc. Neglected Tropical Diseases Diagnosis Revenue (US$ Million) & (2018-2023)
5.3.5 Life Technology Recent Developments
5.4 Life Technology
5.4.1 Life Technology Profile
5.4.2 Life Technology Main Business
5.4.3 Life Technology Neglected Tropical Diseases Diagnosis Products, Services and Solutions
5.4.4 Life Technology Neglected Tropical Diseases Diagnosis Revenue (US$ Million) & (2018-2023)
5.4.5 Life Technology Recent Developments
5.5 Novartis Diagnostics., Ltd.
5.5.1 Novartis Diagnostics., Ltd. Profile
5.5.2 Novartis Diagnostics., Ltd. Main Business
5.5.3 Novartis Diagnostics., Ltd. Neglected Tropical Diseases Diagnosis Products, Services and Solutions
5.5.4 Novartis Diagnostics., Ltd. Neglected Tropical Diseases Diagnosis Revenue (US$ Million) & (2018-2023)
5.5.5 Novartis Diagnostics., Ltd. Recent Developments
5.6 Ortho-Clinical Diagnostics
5.6.1 Ortho-Clinical Diagnostics Profile
5.6.2 Ortho-Clinical Diagnostics Main Business
5.6.3 Ortho-Clinical Diagnostics Neglected Tropical Diseases Diagnosis Products, Services and Solutions
5.6.4 Ortho-Clinical Diagnostics Neglected Tropical Diseases Diagnosis Revenue (US$ Million) & (2018-2023)
5.6.5 Ortho-Clinical Diagnostics Recent Developments
5.7 Premier Medical Corporation Ltd.
5.7.1 Premier Medical Corporation Ltd. Profile
5.7.2 Premier Medical Corporation Ltd. Main Business
5.7.3 Premier Medical Corporation Ltd. Neglected Tropical Diseases Diagnosis Products, Services and Solutions
5.7.4 Premier Medical Corporation Ltd. Neglected Tropical Diseases Diagnosis Revenue (US$ Million) & (2018-2023)
5.7.5 Premier Medical Corporation Ltd. Recent Developments
5.8 Siemens Healthcare
5.8.1 Siemens Healthcare Profile
5.8.2 Siemens Healthcare Main Business
5.8.3 Siemens Healthcare Neglected Tropical Diseases Diagnosis Products, Services and Solutions
5.8.4 Siemens Healthcare Neglected Tropical Diseases Diagnosis Revenue (US$ Million) & (2018-2023)
5.8.5 Siemens Healthcare Recent Developments
5.9 Wako Chemicals, Inc.
5.9.1 Wako Chemicals, Inc. Profile
5.9.2 Wako Chemicals, Inc. Main Business
5.9.3 Wako Chemicals, Inc. Neglected Tropical Diseases Diagnosis Products, Services and Solutions
5.9.4 Wako Chemicals, Inc. Neglected Tropical Diseases Diagnosis Revenue (US$ Million) & (2018-2023)
5.9.5 Wako Chemicals, Inc. Recent Developments
6 North America
6.1 North America Neglected Tropical Diseases Diagnosis Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Neglected Tropical Diseases Diagnosis Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Neglected Tropical Diseases Diagnosis Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Neglected Tropical Diseases Diagnosis Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Neglected Tropical Diseases Diagnosis Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Neglected Tropical Diseases Diagnosis Market Dynamics
11.1 Neglected Tropical Diseases Diagnosis Industry Trends
11.2 Neglected Tropical Diseases Diagnosis Market Drivers
11.3 Neglected Tropical Diseases Diagnosis Market Challenges
11.4 Neglected Tropical Diseases Diagnosis Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
